ReviewRSC medicinal chemistry2026
Stick to the beads: supercharging medicinal chemistry and methodology development with ChemBeads.
Review in RSC medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of an air- and moisture-tolerant MOF-based C-H amination catalyst.Chemical communications (Cambridge, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This perspective explores the development, preparation, and widespread application of ChemBeads, a solid reagent delivery platform designed to overcome longstanding challenges in miniaturized and automated chemical experimentation. Originating from innovation at AbbVie, ChemBeads are formed by dry-coating active reagents onto inert carrier beads, transforming poorly flowing powders into uniform, flowable materials compatible with robotic and manual dispensing. Enabled by resonant acoustic mixing (RAM) or alternative techniques like vortex mixing, ChemBeads have streamlined high-throughput experimentation (HTE) and medicinal chemistry workflows. Their applications span a wide range of transformations including photoredox catalysis, cross-electrophile coupling, C-N and C-H functionalizations and late-stage oxidations. Industrial and academic case studies highlight the critical role of ChemBeads in accelerating the development of new synthetic methodologies that would have otherwise taken significantly longer to accomplish. By solving the long standing problem of material handling at a miniaturized scale with efficiency and generality, ChemBead technology formed the foundation of the AbbVie Discovery HTE platform and positioned us as one of the industry leaders in this field. Over the years, we expanded the technology to make it greatly accessible to academic institutions by making the process economically and operationally friendly. In parallel, we extended this technology in other areas, which ultimately promoted industry-academia collaborations. The technology's expansion into biocatalysis (EnzyBeads), solubility assays, and solid form screening further demonstrates its adaptability.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.